Haemopoietic-cell transplantation (HCT) is an intensive therapy used to treat high-risk
haematological malignant disorders and other life-threatening haematological and genetic …

Chronic graft-versus-host disease (GVHD) is a frequent and potentially life-threatening
complication of allogeneic hematopoietic stem cell transplantation. Increased …

Chronic graft-versus-host disease (cGVHD) is a serious complication of allogeneic stem cell
transplantation with few effective options available after failure of corticosteroids. B and T …

Abstract The 2005 National Institutes of Health (NIH) Consensus Conference proposed new
criteria for diagnosing and scoring the severity of chronic graft-versus-host disease (GVHD) …

Although transplant practices have changed over the last decades, no information is
available on trends in incidence and outcome of chronic graft-versus-host disease (cGVHD) …

Abstract In 2005, the National Institutes of Health (NIH) Chronic Graft-versus-Host Disease
(GVHD) Consensus Response Criteria Working Group recommended several measures to …

Risk factors for grades 2-4 acute graft-versus-host disease (GVHD) and for chronic GVHD as
defined by National Institutes of Health consensus criteria were evaluated and compared in …

This consensus document is intended to serve 3 functions. First, it standardizes the criteria
for diagnosis of chronic graft-versus-host disease (GVHD). Second, it proposes a new …

For over 60 years, hematopoietic stem cell transplantation has been the major curative
therapy for several hematological and genetic disorders, but its efficacy is limited by the …

Chronic graft-versus-host disease (GVHD) remains a vexing and dangerous complication of
allogeneic stem cell transplantation. Mild forms of chronic GVHD are often manageable with …